FindTrial
Sign In

Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01025934
Enrollment
Unknown
Registered
2009-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2009-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proliferative Diabetic Retinopathy

Brief summary

The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.

Interventions

DRUGBevacizumab
OTHERsham

Sponsors

Napoli CTO Hospital
CollaboratorUNKNOWN
University of Campania Luigi Vanvitelli
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* vitreous haemorrhage * tractional retinal detachment * active proliferative diabetic retinopathy.

Exclusion criteria

* neovascular glaucoma * cataract * combined traction and rhegmatogenous RD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026